%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png)
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第三届董事会第十四次会议决议公告 | 2023-02-17 | Chinese | |
| 关于吸收合并全资子公司的公告 | 2023-02-17 | Chinese | |
| 独立董事关于第三届董事会第十四次会议相关事项的独立意见 | 2023-02-17 | Chinese | |
| 关于变更公司董事会秘书的公告 | 2023-02-17 | Chinese | |
| 第三届监事会第十一次会议决议公告 | 2023-02-17 | Chinese | |
| 关于控股股东、实际控制人部分股份解除质押的公告 | 2023-02-14 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
13 filings
| |||||
| 40018866 | 第三届董事会第十四次会议决议公告 | 2023-02-17 | Chinese | ||
| 40018853 | 关于吸收合并全资子公司的公告 | 2023-02-17 | Chinese | ||
| 40018841 | 独立董事关于第三届董事会第十四次会议相关事项的独立意见 | 2023-02-17 | Chinese | ||
| 40018833 | 关于变更公司董事会秘书的公告 | 2023-02-17 | Chinese | ||
| 40018828 | 第三届监事会第十一次会议决议公告 | 2023-02-17 | Chinese | ||
| 40018821 | 关于控股股东、实际控制人部分股份解除质押的公告 | 2023-02-14 | Chinese | ||
| 40018813 | 关于控股股东、实际控制人部分股份解除质押的公告 | 2023-02-08 | Chinese | ||
| 40018806 | 关于公司股东减持股份的预披露公告 | 2023-01-20 | Chinese | ||
| 40018797 | 关于公司股东减持股份比例达到1%的公告 | 2023-01-17 | Chinese | ||
| 40018789 | 药石科技2023年第一次临时股东大会的法律意见书 | 2023-01-16 | Chinese | ||
| 40018780 | 2023年第一次临时股东大会决议公告 | 2023-01-16 | Chinese | ||
| 40018774 | 关于向下修正可转换公司债券转股价格的公告 | 2023-01-16 | Chinese | ||
| 40018772 | 关于2022年第四季度可转债转股情况的公告 | 2023-01-03 | Chinese | ||
|
2022
2 filings
| |||||
| 40018762 | 关于公司控股股东、实际控制人及其一致行动人可转换公司债券比例变动达10%的公告 | 2022-12-30 | Chinese | ||
| 40018761 | 第三届董事会第十二次会议决议公告 | 2022-12-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.